New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
12:05 EDTEBIX, TSN, MNKD, DB, NPSP, NLYOptions with increasing implied volatility
Options with increasing implied volatility: NPSP MNKD EBIX DB TSN NLY
News For NPSP;MNKD;EBIX;DB;TSN;NLY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 2, 2015
08:53 EDTMNKDNon-profit gives lukewarm review to MannKind inhaled insulin, TheStreet says
Subscribe for More Information
06:32 EDTDBLarge EU banks may come under scrutiny for reciprocity, WSJ says
The banking practice of reciprocity -- giving work to competitor banks in order to foster relationships or reward past deals -- may come under investigation by the U.K. Financial Conduct Authority, reports the Wall Street Journal, citing a person familiar with the regulator. The FCA believes the practice may be anticompetitive, but it hasn't yet determined the scope of its investigation into EU banks. Publicly traded companies in the space include Banco Santander (SAN), Barclays (BCS), Credit Suisse (CS), Deutsche Bank (DB), HSBC (HSBC), ING Groep (ING), Lloyds Banking (LYG), RBS (RBS) and UBS (UBS). Reference Link
06:05 EDTMNKDStocks with implied volatility movement; MNKD MRVL
Subscribe for More Information
February 27, 2015
10:32 EDTMNKDOptions with decreasing implied volatility
Subscribe for More Information
08:29 EDTDBJPMorgan, Deutsche Bank pause plans for $2B Argentina bond sale, WSJ says
Deutsche Bank (DB) and JP Morgan (JPM) have suspended plans to sell $2B of Argentinian bonds after a U.S. district judge ordered an emergency hearing on the potential sale, reports the Wall Street Journal, citing people familiar with the matter. The sources said the banks believed they had found a way to sell the bonds without being blocked by a prior U.S. court ruling.Reference Link
06:18 EDTDBBarclays likely to delay forex settlement, FT says
Subscribe for More Information
February 26, 2015
12:48 EDTDBDeutsche Bank co-CEO to stand trial in Germany, Reuters says
Deutsche Bank co-CEO Juergen Fitschen and four former Deutsche board members are set to stand trial in Munich on suspicions of giving misleading evidence during the Leo Kirch trial, reports Reuters, citing Der Spiegel magazine. Reference Link
10:00 EDTDBOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:32 EDTDBDeutsche Bank initiated with an Underperform at Exane BNP Paribas
February 25, 2015
13:34 EDTDBDeutsche Bank hires JPMorgan senior banker Jeff Urwin
Subscribe for More Information
05:52 EDTMNKDStocks with implied volatility movement; MNKD NE
Stocks with implied volatility movement; MannKind (MNKD) 79, Noble Corp. (NE) 52 according to iVolatility.
February 24, 2015
16:48 EDTMNKDMannKind reports Q4 EPS (9c), consensus (9c)
Subscribe for More Information
16:19 EDTNLYAnnaly Capital reports Q4 core EPS 30c, consensus 31c
Reports common stock book value of $13.10, up from $12.87 at prior quarter end. Reports capital ratio of 15.1% and leverage of 5.4:1.
15:21 EDTNLYNotable companies reporting after market close
Subscribe for More Information
13:07 EDTDBEU official: Euro banks shouldn't also go through Fed's stress test, WSJ says
Jonathan Hill, the European Unionís new financial markets chief, told The Wall Street Journal that he does not see a need for the U.S. to give stress tests to European banks that have already received health checks in Europe. Hill says banks across Europe are "properly and sensibly capitalized." The WSJ reported last week that the U.S. units of two European banks, Deutsche Bank (DB) and Banco Santander (SAN), are set to fail the Federal Reserve's stress tests, though they passed ECB stress tests last year. Reference Link
06:36 EDTDBHP obtains ten year outsourcing deal from Deutsche Bank, Reuters reports
Subscribe for More Information
06:15 EDTDBBanks probed for possible rigging of precious metals markets, WSJ reports
Officials in the U.S. are investigating at least 10 major banks for potential rigging of precious-metals markets, sources tell The Wall Street Journal. The DOJ's antitrust unit are investigating the price-setting process for gold, silver, palladium and platinum in London, while the CFTC has begun a civil investigation, with both agencies making requests for information, including a subpoena to HSBC (HSBC) from the CFTC. According to a source, Credit Suisse (CS), JP Morgan (JPM), UBS (UBS), Societe Generale (SCGLY), Bank of Nova Scotia (BNS), Barclays (BCS), Goldman Sachs (GS) and Deutsche Bank (DB) are also under investigation. Reference Link
February 23, 2015
15:06 EDTMNKDMannKind volatility increases into Q4 and outlook
MannKind February weekly call option implied volatility is at 103, March is at 63, April is at 60. May is at 55; compared to its 26-week average of 70 according to Track Data, suggests large near term price movement into the expected release into the expected release of Q4 result on February 24.
February 22, 2015
18:04 EDTNPSPShire completes acquisition of NPS Pharma
Shire (SHPG) announces the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals (NPSP) and the subsequent acquisition of NPS Pharma.The tender offer expired at 12:00 midnight, New York City time, at the end of Friday, February 20, and was not extended. As of the expiration of the tender offer, a total of approximately 88,869,118 common shares of NPS Pharma had been validly tendered and not withdrawn pursuant to the tender offer, representing approximately 81.7% of the outstanding common shares of NPS Pharma. All shares that were validly tendered and not withdrawn pursuant to the tender offer were accepted for payment. After the acceptance of shares that were validly tendered and not withdrawn pursuant to the tender offer, Shire completed the acquisition of NPS Pharma today through a merger of one of Shire's subsidiaries with and into NPS Pharma. In connection with the merger, all common shares of NPS Pharma that were not accepted for payment in the tender offer (excluding any shares held by NPS Pharma as treasury stock (other than any shares held in an NPS Pharma benefit plan) and any shares with respect to which the holders have properly demanded appraisal rights in accordance with Delaware law) were converted into the right to receive $46.00 per share in cash, without interest and less any applicable withholding taxes, the same price that will be paid for shares accepted for payment in the tender offer. Following completion of the merger, NPS Pharma became a wholly owned subsidiary of Shire and NPS Pharma's shares ceased to be traded on NASDAQ.
15:40 EDTDBU.S units of Deutsche Bank, Santander seen failing stress tests, WSJ says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use